ADDITIONAL BENEFITS OF ANTIHYPERTENSIVE MOXONIDINE THERAPY IN POSTMENOPAUSAL WOMEN WITH ARTERIAL HYPERTENSION
https://doi.org/10.15829/1728-8800-2014-1-8-15
Abstract
Aim. To assess the effects of moxonidine in terms of target blood pressure (BP) achievement; to identify potential additional benefits of moxonidine and its effects on bone metabolism and bone mineral density (BMD) in postmenopausal women with arterial hypertension (AH).
Material and methods. The study included 48 postmenopausal women with Stage 1-2 AH, aged 57-71 years.
Results. All participants were divided into two groups by the type of antihypertensive therapy: those receiving moxonidine and those receiving angiotensin-converting enzyme inhibitors / angiotensin receptor antagonists (ACEI/ARA). All women also received calcium and vitamin D. All participants had AH and osteopenia (both in the lumbar spine and proximal femur, according to the X-ray absorptiometry results). In the moxonidine group, BP levels remained within the target range 48 weeks later. There was a significant reduction in the levels of a bone resorption marker (p=0,041), while the dynamics of an osteopoetic marker was statistically non-significant (p=0,31). A tendency towards increasing BMD in lumbar spine and proximal femur was also observed (p=0,059 and p=0,068, respectively). In the ACEI/ARA group, BP levels also remained within the target range 48 weeks later. However, no significant changes in the levels of bone metabolism markers were registered. There was a tendency towards decreasing BMD in lumbar spine and proximal femur (p=0,052 and p=0,054, respectively).
Conclusion. Moxonidine therapy was associated with a significant reduction in bone resorption activity, as demonstrated by the decrease in the concentration of a bone resorption marker, as well as with a tendency towards increasing BMD.
About the Authors
E. N. Dudinskaya
State Research Centre for Preventive Medicine. Moscow, Russia
Russian Federation
Russian Federation
O. N. Tkacheva
State Research Centre for Preventive Medicine. Moscow, Russia
Russian Federation
Russian Federation
References
1. Skripnikova IA. Interrelation of cardiovascular diseases associated with atherosclerosis, and osteoporosis in postmenopausal women. Sovpemennaya rheumatology 2008; 1: 41-7. Russian (Скрипникова И.А. Взаимосвязь сердечно-сосудистых заболеваний, обусловленных атеросклерозом, и остеопорозом у женщин в постменопаузе. Совpeменная ревматология 2008; 1: 41-7).
2. Browner WS, Seeley DG, Vogt TV. Non-trauma mortality in elderly women with low bone mineral density. Study of Osteoporotic Fractures Research Group. Lancet 1991; 338: 335-8.
3. Skripnikova IA, Sobchenko KE, Kosmatova OV, Nebieridze DV. Effect of cardiovascular drugs on bone tissue and the possibility of their use for the prevention of osteoporosis. Rational Pharmacotherapy in Cardiology 2012; 8 (4): 587-94. Russian (Скрипникова И.А., Собченко К.Е., Косматова О.В., Небиеридзе Д.В. Влияние сердечно-сосудистых препаратов на костную ткань и возможность их использования для профилактики остеопороза. Рациональная фармакотерапия в кардиологии 2012; 8(4): 587-94).
4. Riggs BI, Melton LJ. The worldwide problem of osteoporosis: insight affirmed by epidemiology. Bone 1995; 17:505-11.
5. Tanko LB, Christiansen C, Cox DA, et al. Relationship between osteoporosis and cardiovascular disease in postmenopausal women. J Bone Miner Res 2005; 20:1912-20.
6. von der Recke P, Hanse MA, Hassanger C. The association between low bone mass at the menopause and cardiovascular mortality. Am J Med 1999; 106: 273-8.
7. Bartholow M. Top 200 prescription drugs of 2009. Pharmacy Times 2010. Available at: http://www.pharmacytimes.com/publications/issue/2010/May2010/RxFocusTopDrugs-0510. Date of access 29/08/2012.
8. Moore RE, Smith CK, Bailey CS, et al. Characterization of beta-adrenergic receptors on rat and human osteoblast-like cells and demonstration that beta-receptor agonists can simulate bone resorption in organ culture. J Bone Miner Res 1993; 23: 301-15.
9. Rupp H, Eisele B, Ziegler D, et al. United States Patent. Method for the treatment of diseases requiring inhibition or reduction in the activity of pH value-regulating bicarbonate transporter proteins. US 7.309.706.B2. Dec 18, 2007.
10. Hall TJ, Chambers TJ. Optimal bone resorption by isolated rat osteoclasts requires chloride/bicarbonate exchange. Calcif Tissue Int 1989; 45: 378-80.
11. Teti A, Blair HC, Teitelbaum SL, et al. Cytoplasmic pH regulation and chloride/bicarbonate exchange in avian osteoclasts. J Clin Invest 1989; 83: 227-33.
12. Lynn H, Kwok T, Wong SY, et al. Angiotensin converting enzyme inhibitor use is associated with higher bone mineral density in elderly Chinese. Bone 2006; 34(4): 584-8.
13. Hatton R, Stimpel M, Chambers TJ. Angiotensin II is generated from angiotensin I by bone cells and stimulates osteoclastic bone resorption in vitro. J Endocrinol 1997; 152: 5-10.
14. Hiruma Y, Inoue A, Hirose S, Hagiwara H. Angiotensin II stimulates the proliferation of osteoblastrich populations of cells from rat calvariae. Biochem Biophys Res Commun 1997; 230(1): 176-8.
15. Grant FD, Mandel SJ, Brown EM, et al. Interrelationships between the reninangiotensin-aldosterone and calcium homeostatic systems. J Clin Endocrinol Metab 1992; 75: 988-92.
16. Zofkova I, Kanchaeva RL. The effect of nifidepine on serum parathyroid and calcitonin in postmenopausal women. Life Sciences 1995; 57: 1087-96.
17. Hiruma H, Hiruma Y, Inoue F, et al. Deceleration by angiotensin II of the differentiation and bone formation of rat calvarial osteoblastic cells. J Endocrinol 1998; 156: 543-50.
18. Zacharieva S, Shigarminova R, Nachev E, et al. Effect of amlodipine and hormone replacement therapy on blood pressure and bone markers in menopause. Methods Find Exp Clin Pharmacol 2003; 25: 209-13.
Review
For citations:
Dudinskaya E.N., Tkacheva O.N. ADDITIONAL BENEFITS OF ANTIHYPERTENSIVE MOXONIDINE THERAPY IN POSTMENOPAUSAL WOMEN WITH ARTERIAL HYPERTENSION. Cardiovascular Therapy and Prevention. 2014;13(1):8-15. (In Russ.) https://doi.org/10.15829/1728-8800-2014-1-8-15
Views:
814
Email this article 
